Cargando…

4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory Compounds

[Image: see text] Lipoxygenases (LOXs) are a class of enzymes that catalyze the production of pro-inflammatory mediators, such as leukotrienes and lipoxins, via an arachidonic acid cascade as soon as they are released from the membrane phospholipids after tissue injury. In continuation of our effort...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasin, Muhammad, Shahid, Wardah, Ashraf, Muhammad, Saleem, Muhammad, Muzaffar, Saima, Aziz-ur-Rehman, Ejaz, Syed Abid, Saeed, Amna, Majer, Thomas, Bhattarai, Keshab, Riaz, Naheed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202051/
https://www.ncbi.nlm.nih.gov/pubmed/35721976
http://dx.doi.org/10.1021/acsomega.2c01439
_version_ 1784728449507655680
author Yasin, Muhammad
Shahid, Wardah
Ashraf, Muhammad
Saleem, Muhammad
Muzaffar, Saima
Aziz-ur-Rehman,
Ejaz, Syed Abid
Saeed, Amna
Majer, Thomas
Bhattarai, Keshab
Riaz, Naheed
author_facet Yasin, Muhammad
Shahid, Wardah
Ashraf, Muhammad
Saleem, Muhammad
Muzaffar, Saima
Aziz-ur-Rehman,
Ejaz, Syed Abid
Saeed, Amna
Majer, Thomas
Bhattarai, Keshab
Riaz, Naheed
author_sort Yasin, Muhammad
collection PubMed
description [Image: see text] Lipoxygenases (LOXs) are a class of enzymes that catalyze the production of pro-inflammatory mediators, such as leukotrienes and lipoxins, via an arachidonic acid cascade as soon as they are released from the membrane phospholipids after tissue injury. In continuation of our efforts in search for new LOX inhibitors, a series of chlorophenyl-furfuryl-based 1,2,4-triazole derivatives were prepared and evaluated for their 15-LOX inhibitory activities. A simple precursor, 4-chlorobenzoic acid (a), was consecutively transformed into benzoate (1), hydrazide (2), semicarbazide (3), and N-furfuryl 5-(4-chlorobenzyl)-4H-1,2,4-triazole (4), which when further merged with electrophiles (6a–o) resulted in end products (7a–o). The structural elucidations of the newly synthesized compounds (7a–o) were carried out by Fourier transform infrared, (1)H-, (13)C NMR spectroscopy, EI-MS, and HR-EI-MS spectrometry. The inhibitive capability of compounds (7a–o) on soybean 15-LOX was performed in vitro using the chemiluminescence method. The compounds 7k, 7o, 7m, 7b, and 7i demonstrated potent activities (IC(50) 17.43 ± 0.38, 19.35 ± 0.71, 23.59 ± 0.68, 26.35 ± 0.62, and 27.53 ± 0.82 μM, respectively). These compounds revealed 79.5 to 98.8% cellular viability as measured by the MTT assay at 0.25 mM concentration. The structure-activity relationship (SAR) studies showed that the positions and the nature of substituents bonded to the phenyl ring are important in the determination of 15-LOX inhibitory activities. ADME, in silico, and density functional theory studies supported the evidence as yet another class of triazoles with potential lead properties in search for anti-LOX compounds with a safe gastrointestinal safety profile for various inflammatory diseases. Further work is in progress on the synthesis of more derivatives in search for anti-inflammatory agents.
format Online
Article
Text
id pubmed-9202051
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-92020512022-06-17 4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory Compounds Yasin, Muhammad Shahid, Wardah Ashraf, Muhammad Saleem, Muhammad Muzaffar, Saima Aziz-ur-Rehman, Ejaz, Syed Abid Saeed, Amna Majer, Thomas Bhattarai, Keshab Riaz, Naheed ACS Omega [Image: see text] Lipoxygenases (LOXs) are a class of enzymes that catalyze the production of pro-inflammatory mediators, such as leukotrienes and lipoxins, via an arachidonic acid cascade as soon as they are released from the membrane phospholipids after tissue injury. In continuation of our efforts in search for new LOX inhibitors, a series of chlorophenyl-furfuryl-based 1,2,4-triazole derivatives were prepared and evaluated for their 15-LOX inhibitory activities. A simple precursor, 4-chlorobenzoic acid (a), was consecutively transformed into benzoate (1), hydrazide (2), semicarbazide (3), and N-furfuryl 5-(4-chlorobenzyl)-4H-1,2,4-triazole (4), which when further merged with electrophiles (6a–o) resulted in end products (7a–o). The structural elucidations of the newly synthesized compounds (7a–o) were carried out by Fourier transform infrared, (1)H-, (13)C NMR spectroscopy, EI-MS, and HR-EI-MS spectrometry. The inhibitive capability of compounds (7a–o) on soybean 15-LOX was performed in vitro using the chemiluminescence method. The compounds 7k, 7o, 7m, 7b, and 7i demonstrated potent activities (IC(50) 17.43 ± 0.38, 19.35 ± 0.71, 23.59 ± 0.68, 26.35 ± 0.62, and 27.53 ± 0.82 μM, respectively). These compounds revealed 79.5 to 98.8% cellular viability as measured by the MTT assay at 0.25 mM concentration. The structure-activity relationship (SAR) studies showed that the positions and the nature of substituents bonded to the phenyl ring are important in the determination of 15-LOX inhibitory activities. ADME, in silico, and density functional theory studies supported the evidence as yet another class of triazoles with potential lead properties in search for anti-LOX compounds with a safe gastrointestinal safety profile for various inflammatory diseases. Further work is in progress on the synthesis of more derivatives in search for anti-inflammatory agents. American Chemical Society 2022-05-31 /pmc/articles/PMC9202051/ /pubmed/35721976 http://dx.doi.org/10.1021/acsomega.2c01439 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Yasin, Muhammad
Shahid, Wardah
Ashraf, Muhammad
Saleem, Muhammad
Muzaffar, Saima
Aziz-ur-Rehman,
Ejaz, Syed Abid
Saeed, Amna
Majer, Thomas
Bhattarai, Keshab
Riaz, Naheed
4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory Compounds
title 4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory Compounds
title_full 4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory Compounds
title_fullStr 4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory Compounds
title_full_unstemmed 4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory Compounds
title_short 4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory Compounds
title_sort 4-chlorophenyl-n-furfuryl-1,2,4-triazole methylacetamides as significant 15-lipoxygenase inhibitors: an efficient approach for finding lead anti-inflammatory compounds
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202051/
https://www.ncbi.nlm.nih.gov/pubmed/35721976
http://dx.doi.org/10.1021/acsomega.2c01439
work_keys_str_mv AT yasinmuhammad 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT shahidwardah 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT ashrafmuhammad 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT saleemmuhammad 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT muzaffarsaima 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT azizurrehman 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT ejazsyedabid 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT saeedamna 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT majerthomas 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT bhattaraikeshab 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds
AT riaznaheed 4chlorophenylnfurfuryl124triazolemethylacetamidesassignificant15lipoxygenaseinhibitorsanefficientapproachforfindingleadantiinflammatorycompounds